Life Sciences Partners
Investor profile
Investment firm
Life Sciences Partners has backed 9 European tech companies across 13 funding rounds between 2006 and 2019, joining rounds totalling €291M. Most active in Healthtech. Data as of Nov 2026.
Deals
13
distinct rounds
Companies
9
backed
Active span
2006–2019
14 yrs
Total round €
€291M
sum of rounds joined
Deals by year
distinct rounds / yearLife Sciences Partners — deals by year — interactive chart.
Data table
| Life Sciences Partners — deals by year | |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
Top sectors
by dealsLife Sciences Partners — top sectors — interactive chart.
Data table
| Life Sciences Partners — top sectors | |
|---|---|
| Healthtech | 13 |
Stages
by dealsLife Sciences Partners — stages — interactive chart.
Data table
| Life Sciences Partners — stages | |
|---|---|
| Series B | 5 |
| Series C | 4 |
| Series A | 2 |
| Growth/Late | 1 |
| Other | 1 |
Countries
by dealsLife Sciences Partners — countries — interactive chart.
Data table
| Life Sciences Partners — countries | |
|---|---|
| Netherlands | 5 |
| Switzerland | 4 |
| Ireland | 2 |
| Finland | 1 |
| France | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Merus | Netherlands | 3 | €126M |
| DNA Script | France | 1 | €34M |
| Atlantic Therapeutics | Ireland | 1 | €28M |
| Xeltis | Switzerland | 1 | €27M |
| Sequana Medical | Switzerland | 2 | €25M |
| Vivasure Medical | Ireland | 1 | €16M |
| Kuros Biosurgery | Switzerland | 1 | €14M |
| Nexstim | Finland | 1 | €11M |
| Mint Solutions | Netherlands | 2 | €9.4M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Merus | Series C | €73M | 2015-08 |
| DNA Script | Series B | €34M | 2019-04 |
| Merus | Series B | €31M | 2013-10 |
| Atlantic Therapeutics | Series B | €28M | 2019-01 |
| Xeltis | Series B | €27M | 2014-12 |
| Merus | Series A | €22M | 2007-01 |
| Sequana Medical | Series C | €17M | 2014-04 |
| Vivasure Medical | Series C | €16M | 2016-09 |
| Kuros Biosurgery | Growth/Late | €14M | 2015-08 |
| Nexstim | Other | €11M | 2011-01 |